ATE259646T1 - Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von typ ii diabetes, des metabolischen syndroms und assozierten kardiovaskulären erkrankungen - Google Patents

Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von typ ii diabetes, des metabolischen syndroms und assozierten kardiovaskulären erkrankungen

Info

Publication number
ATE259646T1
ATE259646T1 AT99957390T AT99957390T ATE259646T1 AT E259646 T1 ATE259646 T1 AT E259646T1 AT 99957390 T AT99957390 T AT 99957390T AT 99957390 T AT99957390 T AT 99957390T AT E259646 T1 ATE259646 T1 AT E259646T1
Authority
AT
Austria
Prior art keywords
soy protein
diabetes
composition
phytoestrogen
cardiovascular diseases
Prior art date
Application number
AT99957390T
Other languages
English (en)
Inventor
Lars Henrik Hoie
Original Assignee
Nutri Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26064784&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE259646(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutri Pharma As filed Critical Nutri Pharma As
Application granted granted Critical
Publication of ATE259646T1 publication Critical patent/ATE259646T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT99957390T 1998-11-25 1999-11-25 Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von typ ii diabetes, des metabolischen syndroms und assozierten kardiovaskulären erkrankungen ATE259646T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199801556 1998-11-25
DKPA199900856 1999-06-16
PCT/IB1999/001992 WO2000030663A1 (en) 1998-11-25 1999-11-25 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases

Publications (1)

Publication Number Publication Date
ATE259646T1 true ATE259646T1 (de) 2004-03-15

Family

ID=26064784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99957390T ATE259646T1 (de) 1998-11-25 1999-11-25 Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von typ ii diabetes, des metabolischen syndroms und assozierten kardiovaskulären erkrankungen

Country Status (9)

Country Link
EP (1) EP1143988B1 (de)
JP (1) JP2003524610A (de)
AT (1) ATE259646T1 (de)
AU (1) AU1511300A (de)
BR (1) BR9915693A (de)
CA (1) CA2352510A1 (de)
DE (1) DE69914947D1 (de)
HK (1) HK1041636A1 (de)
WO (1) WO2000030663A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1171119A1 (de) 1999-04-20 2002-01-16 The Board Of Trustees Of Southern Illinois University Methoden zur behandlung klinischer erkrankungen mit isoflavonen
AU779014B2 (en) * 1999-04-23 2005-01-06 Archer-Daniels-Midland Company Composition for and method of reducing low density lipoprotein cholesterol concentration
US6544566B1 (en) 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
AU783820B2 (en) * 1999-04-23 2005-12-08 Archer-Daniels-Midland Company Composition for and method of reducing low density lipoprotein cholesterol concentration
US7285297B1 (en) 1999-04-23 2007-10-23 Archer-Daniels-Midland Company Method of reducing low density liproprotein cholesterol concentration
KR20030005280A (ko) 2000-04-14 2003-01-17 마아즈, 인코오포레이티드 혈관의 건강을 개선하기 위한 조성물과 방법
JP2011105763A (ja) * 2000-06-21 2011-06-02 Kao Corp Ｐｐａｒ依存的遺伝子転写活性化剤
US6365176B1 (en) * 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
EP1361870A2 (de) * 2001-02-01 2003-11-19 Nutri Pharma ASA Eine substanz zur verwendung in einem diätzusatz oder zur herstellung eines medikaments zur behandlung von nicht-insulin-abhängigen diabetes mellitus, bluthochdruck und/oder des metabolischen syndroms
FI20010780A0 (fi) 2001-04-12 2001-04-12 Raisio Benecol Oy Parannetut koostumukset
US6559177B2 (en) 2001-04-19 2003-05-06 Wyeth 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
US6589980B2 (en) 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
AU2002345255A1 (en) * 2001-07-03 2003-01-21 Nutri Pharma Danmark Holding A/S Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
US6787151B2 (en) 2001-08-10 2004-09-07 Lipton, Division Of Conopco, Inc. Composition for lowering blood cholesterol
GB0125662D0 (en) * 2001-10-26 2001-12-19 Chapman Thomas B Formultion
WO2003070018A2 (en) * 2002-02-22 2003-08-28 Nutri Pharma Asa Food products comprising soy protein
AU2003215774A1 (en) * 2002-02-23 2003-09-09 Nutri Pharma Asa Method for manufacturing beads containing exogenous soy protein
EP1480525A2 (de) * 2002-02-23 2004-12-01 Nutri Pharma ASA Neue sojaproteinprodukte
NZ536466A (en) * 2002-04-18 2008-04-30 Monsanto Technology Llc Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
CA2492754C (en) 2002-07-24 2018-05-22 Children's Hospital Medical Center Compositions and products containing enantiomeric equol, and methods for their making
US8668914B2 (en) 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
CA2504682A1 (en) 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
JP2008007452A (ja) * 2006-06-28 2008-01-17 Ajinomoto Co Inc 膵β細胞保護剤
BRPI0715740A8 (pt) * 2006-08-21 2017-01-24 Calpis Co Ltd Agente redutor de triglicerídeos séricos
DE102006040456A1 (de) * 2006-08-25 2008-02-28 Constantin Nies Verzehrbare flächige Darreichungsform von Nahrungsergänzungsmitteln und/oder Arzneiwirkstoffen zur Ergänzung von fertigen oder halbfertigen Nahrungsmitteln
US9101161B2 (en) 2006-11-02 2015-08-11 The Coca-Cola Company High-potency sweetener composition with phytoestrogen and compositions sweetened therewith
CN102919739B (zh) 2007-06-13 2014-07-02 大塚制药株式会社 含雌马酚的提取物、其制备方法、雌马酚的提取方法及含雌马酚的食品
JP2011006369A (ja) * 2009-06-29 2011-01-13 Kao Corp Ｐａｉ−１低下剤
CA2990230A1 (en) 2015-06-19 2016-12-22 University Of Southern California Compositions and methods for modified nutrient delivery
WO2016205701A1 (en) 2015-06-19 2016-12-22 University Of Southern California Enteral fast access tract platform system
USD767243S1 (en) 2015-09-03 2016-09-27 The J.M. Smucker Company Coated food product
USD767244S1 (en) 2015-09-03 2016-09-27 The J.M. Smucker Company Coated food product
USD767241S1 (en) 2015-09-03 2016-09-27 The J.M. Smucker Company Coated food product
USD767242S1 (en) 2015-09-03 2016-09-27 The J.M Smucker Company Coated food product
WO2021064107A1 (en) 2019-10-02 2021-04-08 Norvia Nutrition Ltd. Composition comprising soy and use thereof in the prevention and/or treatment of microvascular or lipoprotein related diseases, microcardiovascular diseases, atherosclerosis, hypertension, and in patients with such cardiovascular disorders suffering from alzheimer and dementia, overweight and obesity, type 2 diabetes, asthma and other disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2395288A1 (fr) * 1977-06-23 1979-01-19 Ppn Nouvelles compositions therapeutiques destinees notamment a la prevention et au traitement des maladies de plethore
DK171752B1 (da) * 1992-07-06 1997-05-12 Birgitte Stilling Brødlignende produkt med blodsukkersænkende virkning til diabetikere samt pulverformig blanding til anvendelse ved fremstilling deraf
CA2249366C (en) * 1996-04-09 2001-06-12 Donald Lee Crank Novel isoflavone-enriched soy protein product and method for its manufacture
AU3887597A (en) * 1996-07-18 1998-02-10 Nutricor, Inc. Nutritious food preparations and methods for making them
EP1310173B2 (de) * 1997-06-23 2014-12-31 Société des Produits Nestlé S.A. Zusammensetzung zur Ernährung von Diabetikern

Also Published As

Publication number Publication date
AU1511300A (en) 2000-06-13
DE69914947D1 (de) 2004-03-25
WO2000030663A1 (en) 2000-06-02
HK1041636A1 (zh) 2002-07-19
CA2352510A1 (en) 2000-06-02
EP1143988A1 (de) 2001-10-17
JP2003524610A (ja) 2003-08-19
BR9915693A (pt) 2001-08-14
EP1143988B1 (de) 2004-02-18

Similar Documents

Publication Publication Date Title
ATE259646T1 (de) Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von typ ii diabetes, des metabolischen syndroms und assozierten kardiovaskulären erkrankungen
ATE253925T1 (de) Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von kardiovaskulären erkrankungen
ATE242638T1 (de) Verwendung einer zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen zur vorbeugung und/oder behandlung von lungenerkrankungen
ATE297726T1 (de) Forskolin zur entwicklung magerer körpermasse
ATE279163T1 (de) Gewebedezellularization
TR200000077T1 (tr) Dekubitus ülserlerinin tedavisi için besin terkibi.
PT1562681E (pt) Peúga
ATE259644T1 (de) Behandlung von hämoglobin enthaltenden erythrozyten mit stickstoffoxyd
DE69713300D1 (de) Benzopyran derivate mit leukotrien-antagonistischer wirkung
TR200103634T2 (tr) Bitkilerde flavonoidlerin ve fenolik maddelerin miktarını arttırma yöntemi.
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
RU2003117446A (ru) Косметический способ лечения кожи
ATE289816T1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
ATE499944T1 (de) Verwendung von einem extrakt von einem nicht- photosynthetischen faserigen bakterium zur beförderung der herstellung von superoxid- dismutase
BR0009592A (pt) Composição anti-diabética, e, método para tratamento de diabetes mellitus
ATE61524T1 (de) Verwendung von hyperoxygenierten oelen zur herstellung eines arzneimittells zur behandlung von herpes.
DE60304461T8 (de) Verwendung von pflanzlichem material zur bekämpfung von landschnecken
HK1073228A1 (en) Aromatic herb preparation
DE60103658D1 (de) Ex-vivo unter oxidativen stress behandelte cll-zellen zur behandlung chronischer lymphozytärer läukemie (cll)
ATE363273T1 (de) Verwendung von itakonsäure zur regulierung des glykolytischen stoffwechsels
BR9906824A (pt) "composições de desacidificação para tratamento de materiais celulósicos impressos e de tratamento de desacidificação para materiais celulósicos impressos, e, processos para produzir uma composição de tratamento de desacidificação para materiais celulósicos impressos, para o tratamento de desacidificação de materiais celulósicos impressos e para reduzir o teor de umidade em solventes."
AU2003230830A8 (en) Treatment of type 1 diabetes before and after expression of predisposition markers
ATE450267T1 (de) Verwendung von ginkgo biloba extrakten zur förderung der muskelmasse zum nachteil der fettmasse
DE59407576D1 (de) Verwendung von Etofibrat und pharmazeutische Zusammensetzungen, enthaltend Etofibrat, zur Behandlung der diabetischen Angio- und Retinopathie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties